Wednesday , March 3 2021

Pancreas Cancer: A great killer battle with research weapons


Pancreas cancer is one of the most aggressive cancers, and unfortunately its activity is becoming more pronounced: more than 1,200 tests are taking place around the world.

Although we talk about a very dangerous tumor, current research is not funding enough, in fact only 2% of all funds in Europe.

The association joins together researchers, researchers and patients with the Viaola Code. Dealing with different subjects about diagnosis: Identifying early symptoms in diagnostic and diagnostic means from malnutrition to research evolution. These events eventually move forward: even in the early stages of the disease, new biomarkers recognize the advanced diagnosis. (Identifying three of these, pancreatic cancer is higher in the blood of cancer patients than the healthiest issues) The relationship between cancer and immune system.

«This tumor often seems to be the accusation, but its natural history really changes – the possibilities of the possibilities open the way for developing new chemotherapy treatments, Alasandro Surby, Pancreatic Surgical Manual or Professor Humanitas University Manager explains. With the intervention of the surgery, the most complicated and their success depends on the authenticity of the center and the performance they do. Combined with all research and development, attention is paid to the biological characteristics of pancreas cancer.

Pancreatic cancer is an expression of unusual cells in pancreats. Pancreas is located on the stomach, behind the stomach, which produces digestive and insulin. Pancreas contains two types of tissues that can perform different functions: secreting the enzymes of the gastrointestinal tract. Xihrine pancreas *, fat proteins, helps in the digestive process of proteins, glucagon * Endocrinous pancreas * secretly administered by insulin to control blood sugar levels It flows in the bleeding. More than 80 percent of cases, pancreas neoplasis develop into acryrin pancreas. Pancreas's head or neck is 75% of the tumors in the pancreas of the crown. 15-20% tail and 5-10% of the body.

Is there a pancreas cancer factor?

Pancreatic cancer is the most common seventh malingent gland in Europe. Pancreatic cancer in the European Union affects 11.6 males per 100,000 people every year. 4.7 (Cyprus) and 17.2 (Hungary) are new cases. 35,000 people die. The male population. About 8.1 women in pancreatic cancer are reported to be about 100,000 women. There are new cases in Cyprus (in Cyprus) and 11.4 (Finland). Even in women, this phenomenon can cause 35,000 deaths every year. Regeneration of newly diagnosed cases increases the age and affects most of them over 65 years of age. In many cases, cancer is becoming more common in other organs because this disease is often not serious. Cancer mortality is the fifth most serious cancer killer.

What is Western Cancer Cancer?

It is unclear why Pancreatic Cancer is developing. Although most pancreas tumors (90%) may not be of any kind of risk, some of the risks have been identified *. Risk factors may increase the risk of developing cancer, but it is not necessarily a requirement or cause. The risk factors are not in one way. Some people with these risk factors do not develop pancreatic cancer. It may be developed by others who did not have these risks. The main risk factors for pancreatic cancer are: – Genes: Some genetic mutations are known to have pancreatic cancer.

Somatic mutation has most of the pancreas neo-phases on KRAS (80%), p53 (50%) and p16 genes. Other genes showing pancreatic cancer or mutations show that CDKN2 (90%), DPC4 / Smad4 (50%). BRCA2 is another museum responsible for the decentralization of the conjunctivitis and the depression of the depressive neoplastic syndrome. Some pancreas tumors have shown that BRCA2 has been affected early on. Traditional pankriyarris, pyurrs-jegers Syndrome *, multi-vitamin and Nevis melanoma, melanoma mole Multi-Family Traditional disabilities, family paramparyareagannal, paramparyareagannal, paramparyareagannal, Colorado kealarikrral conventional cancer (cancer of renewable and non-pealipeasis kealaraktal, eccenpisisi or Lynch syndrome) and pancreas cancer develops More likely to be cleaned. Refers to classical interpretations from one generation to the other of genetic characters. The first (parents, brother / sister) or second degree (uncle, aunt, or relative) who have a pancreas cancer is likely to develop a patient. Family members may have between 5% and 10% of pancreas tumors. Cigarette smoking: Smoking cigarettes for up to 25% of pancreatic cancer patients

If the patient is infected with one of the above gene syndromes, smoking habit is very effective. Age: The possibility of developing pancreatic cancer is slowing down. Most pancreas tumors are among those aged between 60 and 80 years. – Obesity: Available evidence suggests that the possibility of developing pancreas cancer increases slightly as the body mass index increases. Body weight Index is a parameter that expresses the connection between weight and height, indicating obesity and underweight. – Chronic pancreatitis: In many decades, it increases the risk of pancreatic adonacrazosis *. This risk increases with the nature of smoke and genetic factors.

What is the cancer of the pastors?

Pancreas tumers have no effective screening methods since so far none of the screening programs are recommended for the general population. Internal structure Pancreasitive cancers and Princensor Rug * No symptoms before it. Early detection of pancreatic cancer is very difficult and it is very rare to detect the infection in the early stages. However, patients with any of the above mentioned trademarks were usually endoscopic ultrasound (EUS). It helps to identify minor listening and magnetic resonance imaging (MRI). The suspicion of pancreatic cancer may occur in the presence of several symptoms. Excess weight, jaundice, abdominal pain or pain. Many symptoms may be present in these symptoms to detect pancreatic cancer. Sometimes, patients present diabetes or pancreatitis for new diagnosis. The pancreatic cancer diagnosis is based on the following tests: 1. Clinical exam. Some of the symptoms found in the clinical exam are from pancreatic cancer patients: Yellow fever is an important symptom, but it can cause pancreasine cannibar. It is yellow and yellow. This is the increase in bilirubin levels in blood. This can be done with the tumor to hamper the normal cannon, which is more likely to pancreas on the head. This barrier causes the bile to reach the gallbladder, which can be broadened further. The usual bile is dumped because the bowel does not adorn the bowel and the feces are white. If the level of bilirubin in the blood increases, the bilirubin will be driven out of the urine due to the three-quarters of the body and become dark in the urine. Pain in the stomach and back pains due to tumor stress in the structure of nerves. This symptom is particularly common if the tumor is in the tail of the body or pancreas. Significant signs of loss of losing weight and loss of appetite. If digestive disruption disrupts the pancreas that connects ordinary cannons, digestion reduces enzymes to digestible food. It can cause nausea, vomiting and diarrhea.

Source link